Skip to main content
. 2011 May 25;18(6):859–867. doi: 10.1136/amiajnl-2011-000121

Table 3.

Comparison of problem-only, billing-only, and problem inference rule performance

F0.5
Billing (b) Rules (r) Problems (p) r>b r>p
ADHD 84.6 81.9 71.1 N Y
Asthma/COPD 90.4 90.2 70.9 N Y
Breast cancer 97.8 98.3 91.6 Y Y
CAD 88.2 94.1 81.1 Y Y
CHF 74.1 76.6 24.8 Y Y
Diabetes 89.7 93.7 83.0 Y Y
Glaucoma 94.4 95.6 89.2 Y Y
Hemophilia 91.1 93.7 89.4 Y Y
Hypertension 87.2 86.2 75.5 N Y
Hyperthyroidism 72.3 87.5 81.4 Y Y
Hypothyroidism 78.1 92.7 76.3 Y Y
Myasthenia gravis 62.8 84.7 73.9 Y Y
Osteoporosis/osteopenia 85.0 82.9 71.1 N Y
Renal insuf/renal fail 65.0 83.8 12.9 Y Y
Rheumatoid arthritis 86.1 81.4 48.4 N Y
Sickle cell disease 75.3 92.9 90.6 Y Y
Stroke 90.8 94.1 88.7 Y Y

ADHD, attention deficit hyperactivity disorder; CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; fail, failure; insuf, insufficiency.